• Topics

  • Formats

Organiser: DIA

Speaker(s): Daniel Pointing & Ryan Zettle

AI workflow solutions are moving into regulatory work faster than most teams can evaluate it. Meanwhile, authoring bottlenecks, drawn-out review cycles, and tight health authority timelines keep piling pressure on teams, and the standard for quality can't move. The real opportunity isn't choosing between AI and human judgment, it's knowing exactly where each does its best work, and where they're strongest combined. Weave and Parexel take on that question together: an AI-native platform built specifically for the regulatory process in drug development, paired with the regulatory expertise and firsthand view of what health authorities expect. Drawing on real deployment experience across organizations of various sizes, they get specific about where AI accelerates the work, where regulatory judgment has to lead, and how the two work best in tandem. Using real examples, they'll show exactly what that looks like in practice.

AI is reshaping the regulatory process in drug development. Join Weave and Parexel on speed, judgment, and where they meet.

Available Dates

Reading this content is completely free

Enjoy Unlimited Access and Unlock
Additional Features with a Free Account

Join Now

You are attempting to log out of MyMA

Do you really want to log out?